589 related articles for article (PubMed ID: 9024793)
1. Bone morphogenetic protein-2 inhibits terminal differentiation of myogenic cells by suppressing the transcriptional activity of MyoD and myogenin.
Katagiri T; Akiyama S; Namiki M; Komaki M; Yamaguchi A; Rosen V; Wozney JM; Fujisawa-Sehara A; Suda T
Exp Cell Res; 1997 Feb; 230(2):342-51. PubMed ID: 9024793
[TBL] [Abstract][Full Text] [Related]
2. Smad1 and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts.
Yamamoto N; Akiyama S; Katagiri T; Namiki M; Kurokawa T; Suda T
Biochem Biophys Res Commun; 1997 Sep; 238(2):574-80. PubMed ID: 9299554
[TBL] [Abstract][Full Text] [Related]
3. A kinase domain-truncated type I receptor blocks bone morphogenetic protein-2-induced signal transduction in C2C12 myoblasts.
Namiki M; Akiyama S; Katagiri T; Suzuki A; Ueno N; Yamaji N; Rosen V; Wozney JM; Suda T
J Biol Chem; 1997 Aug; 272(35):22046-52. PubMed ID: 9268344
[TBL] [Abstract][Full Text] [Related]
4. MyoD enhances BMP7-induced osteogenic differentiation of myogenic cell cultures.
Komaki M; Asakura A; Rudnicki MA; Sodek J; Cheifetz S
J Cell Sci; 2004 Mar; 117(Pt 8):1457-68. PubMed ID: 15020674
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of the Ski-interacting protein (SKIP) on differentiation induced by transforming growth factor-beta1 and bone morphogenetic protein-2 in C2C12 cells.
Figueroa JD; Hayman MJ
Exp Cell Res; 2004 Jun; 296(2):163-72. PubMed ID: 15149847
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic protein inhibits differentiation and affects expression of helix-loop-helix regulatory molecules in myoblastic cells.
Murray SS; Murray EJ; Glackin CA; Urist MR
J Cell Biochem; 1993 Sep; 53(1):51-60. PubMed ID: 7693731
[TBL] [Abstract][Full Text] [Related]
7. Mutation of Thr115 in MyoD positively regulates function in murine fibroblasts and human rhabdomyosarcoma cells.
Liu LN; Dias P; Houghton PJ
Cell Growth Differ; 1998 Sep; 9(9):699-711. PubMed ID: 9751114
[TBL] [Abstract][Full Text] [Related]
8. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage.
Katagiri T; Yamaguchi A; Komaki M; Abe E; Takahashi N; Ikeda T; Rosen V; Wozney JM; Fujisawa-Sehara A; Suda T
J Cell Biol; 1994 Dec; 127(6 Pt 1):1755-66. PubMed ID: 7798324
[TBL] [Abstract][Full Text] [Related]
9. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation.
Lee MH; Javed A; Kim HJ; Shin HI; Gutierrez S; Choi JY; Rosen V; Stein JL; van Wijnen AJ; Stein GS; Lian JB; Ryoo HM
J Cell Biochem; 1999 Apr; 73(1):114-25. PubMed ID: 10088730
[TBL] [Abstract][Full Text] [Related]
10. SV40 T antigen inhibits expression of MyoD and myogenin, up-regulates Myf-5, but does not affect early expression of desmin or alpha 7 integrin during muscle development.
Haider SR; Wang W; Kaufman SJ
Exp Cell Res; 1994 Feb; 210(2):278-86. PubMed ID: 7507852
[TBL] [Abstract][Full Text] [Related]
11. Constitutively active BMP type I receptors transduce BMP-2 signals without the ligand in C2C12 myoblasts.
Akiyama S; Katagiri T; Namiki M; Yamaji N; Yamamoto N; Miyama K; Shibuya H; Ueno N; Wozney JM; Suda T
Exp Cell Res; 1997 Sep; 235(2):362-9. PubMed ID: 9299160
[TBL] [Abstract][Full Text] [Related]
12. Dual promoter structure of ZFP106: regulation by myogenin and nuclear respiratory factor-1.
Grasberger H; Ye H; Mashima H; Bell GI
Gene; 2005 Jan; 344():143-59. PubMed ID: 15656981
[TBL] [Abstract][Full Text] [Related]
13. Effect of phase limited inhibition of MyoD expression on the terminal differentiation of bovine myoblasts: no alteration of Myf5 or myogenin expression.
Muroya S; Nakajima I; Oe M; Chikuni K
Dev Growth Differ; 2005 Sep; 47(7):483-92. PubMed ID: 16179075
[TBL] [Abstract][Full Text] [Related]
14. c-Ski activates MyoD in the nucleus of myoblastic cells through suppression of histone deacetylases.
Kobayashi N; Goto K; Horiguchi K; Nagata M; Kawata M; Miyazawa K; Saitoh M; Miyazono K
Genes Cells; 2007 Mar; 12(3):375-85. PubMed ID: 17352741
[TBL] [Abstract][Full Text] [Related]
15. Evidence that E-box promoter elements and MyoD transcription factors play a role in the induction of cathepsin B gene expression during human myoblast differentiation.
Jane DT; Morvay LC; Koblinski J; Yan S; Saad FA; Sloane BF; Dufresne MJ
Biol Chem; 2002 Dec; 383(12):1833-44. PubMed ID: 12553720
[TBL] [Abstract][Full Text] [Related]
16. Failure of Myf5 to support myogenic differentiation without myogenin, MyoD, and MRF4.
Valdez MR; Richardson JA; Klein WH; Olson EN
Dev Biol; 2000 Mar; 219(2):287-98. PubMed ID: 10694423
[TBL] [Abstract][Full Text] [Related]
17. S100B protein in myoblasts modulates myogenic differentiation via NF-kappaB-dependent inhibition of MyoD expression.
Tubaro C; Arcuri C; Giambanco I; Donato R
J Cell Physiol; 2010 Apr; 223(1):270-82. PubMed ID: 20069545
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional activation of the myogenin gene by MEF2-mediated recruitment of myf5 is inhibited by adenovirus E1A protein.
Johanson M; Meents H; Ragge K; Buchberger A; Arnold HH; Sandmöller A
Biochem Biophys Res Commun; 1999 Nov; 265(1):222-32. PubMed ID: 10548518
[TBL] [Abstract][Full Text] [Related]
19. Exogenous hepatocyte growth factor inhibits myoblast differentiation by inducing myf5 expression and suppressing myoD expression in an organ culture system of embryonic mouse tongue.
Yamane A; Amano O; Urushiyama T; Nagata J; Akutsu S; Fukui T; Diekwisch TG
Eur J Oral Sci; 2004 Apr; 112(2):177-81. PubMed ID: 15056116
[TBL] [Abstract][Full Text] [Related]
20. Brefeldin A inhibits muscle-specific gene expression during differentiation in C2C12 myoblasts.
Ichikawa K; Mimura N; Asano A
Exp Cell Res; 1993 Dec; 209(2):333-41. PubMed ID: 8262151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
